Related Experiment Video
Updated: Mar 28, 2026

11:42
Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
9.9K
Evolution of cellular morpho-phenotypes in cancer metastasis
Pei-Hsun Wu1,2, Jude M Phillip1,2, Shyam B Khatau1,2
1Johns Hopkins Physical Sciences - Oncology Center, The Johns Hopkins University, Baltimore, Maryland 21218, USA.
Scientific Reports
|December 18, 2015
Summary
Metastatic cancer cells show less diversity than primary tumors. New imaging tools help analyze cell shapes and understand cancer progression, aiding in predicting patient outcomes.
Area of Science:
- Oncology
- Biotechnology
- Computational Biology
Background:
- Intratumoral heterogeneity complicates cancer progression studies and outcome prediction.
- Understanding cellular diversity is crucial for effective cancer research.
Purpose of the Study:
- To develop an automated high-throughput cell-imaging platform (htCIP) for high-content single-cell analysis.
- To create a visually-aided morpho-phenotyping recognition (VAMPIRE) tool for analyzing cellular and nuclear shapes.
- To investigate heterogeneity differences between primary and metastatic cancer cells.
Main Methods:
- Development of an automated high-throughput cell-imaging platform (htCIP).
- Creation of the visually-aided morpho-phenotyping recognition (VAMPIRE) tool for 2D and 3D shape analysis.
- Analysis of ~39,000 cells from pancreatic cancer patients and 10 breast cancer cell lines.
Main Results:
- Metastatic cells exhibit significantly lower heterogeneity compared to primary tumor cells.
- A consistent morphological signature for metastasis was identified in both pancreatic and breast cancer samples.
- The study identified contributions to heterogeneity from cell cycle, cell-cell contact, stochasticity, and heritable variations.
Conclusions:
- Metastasis is associated with reduced cellular heterogeneity.
- The developed htCIP and VAMPIRE tools provide novel methods for dissecting cancer heterogeneity.
- Findings offer insights into the molecular mechanisms of cancer progression and metastasis.
Related Concept Videos
Metastasis
6.8K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.8K
Adaptive Mechanisms in Cancer Cells
7.4K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.4K
Adaptive Mechanisms in Cancer Cells
4.3K
4.3K
Tumor Progression
7.8K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.8K
Tumor Progression
3.5K
3.5K
Cancer Cell Migration through Invadopodia
3.5K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.5K

